Acute myeloid leukemia patients were found to have higher levels of indoleamine 2,3 dioxygenase (IDO) enzyme that suppresses the immune system leading to early death in patients, reveals a new study.
from Latest Cancer News http://ift.tt/2lbnBz2
Latest Cancer News
Reviewed by MZ Digital Marketing Agency
on
December 28, 2017
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.